France’ s health ministry today reported the country ’ s first clade 1b mpox case, which involves a person from Brittany who ...

SARASOTA, FL, Jan. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad ...

CTX-10726 (a novel PD-1 x VEGF-A bispecific) is advancing as a new drug candidate after a year of preclinical development, with YE 2025 IND expected. Two Phase 2 biomarker trials are expected to ...

"We believe that 2025 will be a pivotal year for SELLAS as we continue to advance our clinical stage portfolio of novel therapeutics for hematologic malignancies,” said Angelos ...

Novo Nordisk shares fell nearly 30% in the fourth quarter on disappointing clinical trial data, and other concerns. Bank of ...

Robust 359 patient trial met primary endpoint with statistically significant reduction in PANSS total score at all dose levels compared to ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

The antiviral pill Paxlovid might help some patients who are suffering from long COVID.A five-day course of Paxlovid ...

Catch up on the clinical trial news, updates from the United States Food and Drug Administration (FDA), and company funding ...

The company also released additional data from its phase 2 clinical trial in addition to the LONGITUDE program design.

Francis Medical Inc., a Twin Cities med-tech manufacturer that's developing a way to treat prostrate and other cancers with water vapor, said Tuesday it raised $80 million in its latest equity funding ...